APA (7th ed.) Citation

Moraes Ribeiro, E., Secker, K., Nitulescu, A., Schairer, R., Keppeler, H., Wesle, A., . . . Schneidawind, D. (2024). PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity. Journal for ImmunoTherapy of Cancer, 12(1), . https://doi.org/10.1136/jitc-2023-007829

Chicago Style (17th ed.) Citation

Moraes Ribeiro, Emmanuelle, et al. "PD-1 Checkpoint Inhibition Enhances the Antilymphoma Activity of CD19-CAR-iNKT Cells That Retain Their Ability to Prevent Alloreactivity." Journal for ImmunoTherapy of Cancer 12, no. 1 (2024). https://doi.org/10.1136/jitc-2023-007829.

MLA (9th ed.) Citation

Moraes Ribeiro, Emmanuelle, et al. "PD-1 Checkpoint Inhibition Enhances the Antilymphoma Activity of CD19-CAR-iNKT Cells That Retain Their Ability to Prevent Alloreactivity." Journal for ImmunoTherapy of Cancer, vol. 12, no. 1, 2024, https://doi.org/10.1136/jitc-2023-007829.